Q2 Results Live: Zydus Wellness Swings To Profit; SBI, NSE Earnings In Focus
Zydus Wellness is in focus in a quarterly results development.
· NDTV Profit
A packed earnings calendar awaits investors, with heavyweight names including SBI, NSE, Bajaj Finserv, MCX, Lupin, Solar Industries, Emcure Pharmaceuticals and Bata India set to unveil their quarterly scorecards.
The analysis
Against that, the stock is +0.6% on the day at ₹486.15, and has returned -16.3% over three months. It sits 19% below its 52-week high. The fmcg sector has moved -8.7% over the same period, so Zydus Wellness is running 7.6 points behind its peers.
For Zydus Wellness, the question is how much of this is already reflected in the price and how much re-rates the fmcg peer set alongside it.
Why it matters
- Earnings versus expectations is what actually re-rates a stock; the surprise matters more than the absolute number.
- The shift to renewables is redrawing which energy names are structural winners versus stranded.
- With NSE involved, this carries a regulatory dimension that can outlast the immediate market reaction.
Market context
- The 6 companies named span 6 sectors, so these are separate company stories rather than one sector-wide move.
- On the day, 5 of 6 are higher: Emcure Pharmaceuticals leads at +8.1% and State Bank of India (SBI) trails at -0.5%.
- Over three months: Zydus Wellness -16.3% against FMCG -8.7% (7.6 points behind); State Bank of India (SBI) -3.9% against Banks -6.0% (2.1 points ahead); Bajaj Finserv -16.6% against Financial Services -13.9% (2.7 points behind); Solar Industries India +5.7% against Defence & Aerospace -0.6% (6.3 points ahead).
- At least 25% below the 52-week high: Bata India (39%).
- Trading well above normal today: Zydus Wellness at 33.5 times its 20-day average volume, State Bank of India (SBI) at 2.4 times its 20-day average volume, Solar Industries India at 3.7 times its 20-day average volume and Emcure Pharmaceuticals at 8.2 times its 20-day average volume.
| Company | Price | Day | 1M | 3M | From 52-wk high | Volume vs 20-day | Market cap |
|---|---|---|---|---|---|---|---|
| Zydus WellnessZYDUSWELL · FMCG | ₹486.15 | +0.6% | -2.0% | -16.3% | -19.3% | 33.5× | — |
| State Bank of India (SBI)SBIN · Banks | ₹982.60 | -0.5% | +3.5% | -3.9% | -20.0% | 2.4× | — |
| Bajaj FinservBAJAJFINSV · Financial Services | ₹1,709.00 | +1.0% | -2.4% | -16.6% | -19.3% | 1.0× | — |
| Solar Industries IndiaSOLARINDS · Defence & Aerospace | ₹20,268.00 | +4.3% | +0.2% | +5.7% | -9.7% | 3.7× | — |
| Emcure PharmaceuticalsEMCURE · Pharma & Healthcare | ₹2,035.20 | +8.1% | -3.1% | -3.9% | +1.3% | 8.2× | — |
| Bata IndiaBATAINDIA · Consumer & Retail | ₹648.50 | +1.7% | +4.0% | -8.4% | -39.4% | 0.6× | — |
FMCG
1M -2.4% · 3M -8.7%
Zydus Wellness
Banks
1M -2.4% · 3M -6.0%
State Bank of India (SBI)
Financial Services
1M -5.1% · 3M -13.9%
Bajaj Finserv
Defence & Aerospace
1M -3.7% · 3M -0.6%
Solar Industries India
Prices as of 3 Nov 2026, 14:41 IST. Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
Stocks to watch: ITC, Lupin, NBCC, SBI, Dr Reddy's, Bosch, Ola Electric
Stocks in news: ITC, Marico, SBI, Yatra Online, NSE, Container Corp and Sun Pharma
Bajaj Finserv Q2 Results: Profit Rises 23% To Rs 2,758 Crore, Total Income Up 17%
SBI Q2 Results: Standalone profit rises 14% YoY to Rs 23,038 crore, NII jumps 15%
SBI posts quarterly profit rise on loan growth, stake sale